Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Uncover various ways to make money effortlessly. These strategies can help you increase your income without overwhelming effort.
13,156 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
When a CFO discloses a sizable stake sale during a volatile period, investors scramble for context. This article brea...
Tech stocks rallied on renewed concerns about memory supply and rising data-center energy costs. Analysts warn that t...
Two major crypto regulations dropping 2026 are on the horizon, touching stablecoins and market infrastructure. This g...
For years, Annaly stock drew steady income seekers. Today, a different financial stock could outperform on yield and ...
Imagine moving to a new home without starting a new loan at a higher rate. Portable mortgages could make that possibl...
Pediatrix Medical Group stock tumbled on Thursday after earnings highlighted modest revenue pressures and GAAP vs non...
Hudbay's 2025 earnings outlook hinges on copper and zinc markets, mine costs, and capital decisions. This guide break...
When a blue-chip pharma stock falls 25%, many investors wonder if it's time to buy. This guide breaks down how to ass...
The beaten-down Figma shares rebound has investors weighing future growth, margins, and valuation. This guide breaks ...
Investors are eyeing kratos (ktos) 2025 earnings as defense programs underpin revenue. This guide breaks down what to...
A wealth manager reduced its position in FIXD by 86,075 shares, cutting the value by roughly $3.8 million. This artic...